Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 421 clinical trials
None
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia

Researchers are looking at two different types of breathing tubes to see if one is better than the other at preventing pneumonia. One of the tubes has a design features to prevent leakage of fluids from the mouth and the back of the throat into the lower airways and lungs. …

intubation
  • 0 views
  • 29 May, 2021
  • 2 locations
None
Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4)

This is a randomized, open label, adaptive platform trial to compare the effectiveness of antithrombotic strategies for prevention of adverse outcomes in COVID-19 positive inpatients

  • 0 views
  • 08 Mar, 2021
  • 41 locations
None
Integrated Platform for Multimodal Patient Monitoring and Therapy Support in ICU Patients

In neurocritical care, besides the standard intensive care monitoring, even more data are obtained from the very complex pathophysiological changes in brain disease. Medical staff for decision-making cannot integrate the huge amount of clinical data generated every second and visualized on different monitors, anymore. Lack of data integration and usability …

  • 0 views
  • 09 Apr, 2021
  • 1 location
None
Assessing the Role of Inclined Positioning in Acute Respiratory Distress Syndrome Patients Recovery

acute respiratory distress syndrome (ARDS) who are in the ICU.

acute respiratory distress
  • 0 views
  • 22 Jun, 2021
  • 1 location
None
Post-Market Study of Low-flow ECCO2R Using PrismaLung+

intended for patients with increased levels of Carbon Dioxide (CO2) in their blood and 18 years old, and will treat patients with mild or moderate acute respiratory distress syndrome (ARDS) using

  • 0 views
  • 16 Aug, 2021
  • 1 location
None
A Phase 2b Multi-Center Randomized Double-Blind Placebo-Controlled Study Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)

hospitalized patients with severe or critical Coronavirus Disease 2019 (COVID-19) with associated acute respiratory distress syndrome (ARDS). Patients will be followed for efficacy and safety for 6 months. The

  • 0 views
  • 29 Aug, 2021
  • 1 location
None
Efficacy Safety Tolerability and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS

The study aims to evaluate MN-166 (ibudilast) in patients with COVID-19 who are at risk of developing acute respiratory distress syndrome. Subjects will be screened, randomly assigned to MN-166

  • 0 views
  • 13 Aug, 2021
  • 2 locations
None
Safety Reactogenicity and Immunogenicity Study of ReCOV

spreading all over the world. This virus can cause acute respiratory distress syndrome (ARDS) with a high fatality rate. In this phase I first-in-human clinical trial, healthy volunteers in two

  • 12 views
  • 01 Sep, 2021
  • 2 locations
None
Use of Extracorporeal CO2 Removal in Case of Moderate to Severe ARDS to Apply an Ultraprotective Mechanical Ventilation Strategy

The extracorporeal CO2 removal (ECCO2R) has been recently proposed in case of Acute Respiratory Distress Syndrome (ARDS) in order to reduce pulmonary injuries induced by the mechanical

  • 0 views
  • 19 Mar, 2021
  • 1 location
None
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome

Background: Systemic corticosteroids are considered in patients with an adverse clinical course suffering from conditions like the acute respiratory distress syndrome (ARDS) and septic

organ dysfunction syndrome
prednisolone
corticosteroids
shock
  • 8 views
  • 07 Nov, 2020
  • 4 locations